May 10–14, 2021
Hybrid Event
Shanghai and Digital

China Showcase Digital at Biotech Showcase


Back on track - VC, Partnering and IPOs exploding

China Showcase | Event Highlights

VC/PE Fundraising

$56.1 billion; 2.3 times 2019

China Showcase | Attendee Profile

VC/PE Investment

$28.5 billion; 2.0 times 2019

China Showcase | Investment Opportunities


$23.3 billion; 2.9 times 2019

China Showcase | One-to-meetings


$30.5 billion; 1.7 times 2019

In 2020, investment in China life science showed stellar growth. ChinaBio®'s survey shows four of the five investment categories set new records, often doubling the year-earlier comparison, while the fifth, Mergers & Acquisitions, fell for the second year in a row.

Report highlights:

Complete the form to download the full report to review in greater detail the record-setting investment and partnering activity.

Get your share of the pie!

2 days in-person. 3 days virtually.

ChinaBio®  Partnering Forum will take place on May 10–14, 2021 as our first hybrid event.
The first two days of the event will be held in-person at the ATLATL campus in Shanghai, China followed by three days of virtual one-to-one meetings, live and on-demand program sessions, company presentations and showcases, networking opportunities and much more.



  • One-to-one meetings
  • Tabletop exhibit opportunities
  • Tailored sponsorship packages
  • One-to-one meetings
  • Company presentation opportunities
  • Company showcase opportunities
  • Tailored sponsorship packages

Learn more about ChinaBio® Partnering Forum and how you get can involved here.


Learn more about the overall factors driving China life science investment and the key players in cross-border deals.

Special report by:

Supporter: ChinaBio Group

All Rights Reserved. Forward ® 2021. EBD Group Inc., 3150 Pio Pico Drive, Suite 201, Carlsbad, CA 92008

State of China Life Science: 2021 Report